|Podcasts|June 18, 2009

Rewards for Subjects, an Ethical Dilemma?

Rewards for Subjects, an Ethical Dilemma?

Felix Gyi, PharmD, MBA, CEO of Chesapeake Research Review discusses ethical rewards for patients in clinical studies and how the relationships between pharma and health care professionals affects subject recruitment and retention.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Trending on Applied Clinical Trials Online

Rewards for Subjects, an Ethical Dilemma?

Related Content

Unlock Commercial Growth through Data-Driven Patient and HCP Insights Podcast

Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit

Thinking Big for Small and Mid-Sized Biotechs: How Applying Modeling and Simulation Technologies Can Improve Drug Development

The Evolving Relationship Between Sponsors and the Contract Research Organizations

The MDR: Navigating Europe’s New Standard for Medical Device Safety

Trending on Applied Clinical Trials Online

ACT Brief: Multimodal AI Systems Architecture, Trust-Based Trial Recruitment, and Big Pharma AI Transformation

ACT Brief: Simplifying Trials Through Selective Safety Data, AI-Driven Site Partnerships, and Biopharma Strategic Pivots

Beyond Eligibility: Making Trust and Behavioral Readiness Actionable in Clinical Trial Recruitment

Tailoring Your FSP Approach: Why One Model Doesn’t Fit Every Trial

AI-Enabled Systems Medicine: From Digital Promise to Clinical Operating Model